Nicolay U - Search Results

1

[Diphtheria antitoxin level 2 years after booster vaccination].

Nicolay U, Girgsdies OE, Banzhoff A, Hundt E, Kondler-Budde R, Lober R, Hainz R, Jilg W. Nicolay U, et al. Wien Med Wochenschr. 2000;150(22):435-9. Wien Med Wochenschr. 2000. PMID: 11191952 Clinical Trial. German.

2

Diphtheria booster vaccination: one or two injections?

Nicolay U, Girgsdies OE, Banzhoff A, Hundt E, Jilg W. Nicolay U, et al. Vaccine. 1999 May 4;17(18):2223-8. doi: 10.1016/s0264-410x(99)00013-4. Vaccine. 1999. PMID: 10403589 Clinical Trial.

3

Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.

Schöndorf I, Schönfeld C, Nicolay U, Zent O, Banzhoff A. Schöndorf I, et al. Among authors: nicolay u. Int J Med Microbiol. 2006 May;296 Suppl 40:208-12. doi: 10.1016/j.ijmm.2006.01.009. Epub 2006 Mar 10. Int J Med Microbiol. 2006. PMID: 16531118

4

Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21).

Schoendorf I, Ternak G, Oroszlàn G, Nicolay U, Banzhoff A, Zent O. Schoendorf I, et al. Among authors: nicolay u. Hum Vaccin. 2007 Mar-Apr;3(2):42-7. doi: 10.4161/hv.3.2.3747. Epub 2007 Mar 22. Hum Vaccin. 2007. PMID: 17297298 Clinical Trial.

5

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.

Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, Wasi C. Briggs DJ, et al. Among authors: nicolay u. Bull World Health Organ. 2000;78(5):693-8. Bull World Health Organ. 2000. PMID: 10859864 Free PMC article. Clinical Trial.

6

Purified Chick Embryo Cell Culture Rabies Vaccine: interchangeability with Human Diploid Cell Culture Rabies Vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons.

Briggs DJ, Dreesen DW, Nicolay U, Chin JE, Davis R, Gordon C, Banzhoff A. Briggs DJ, et al. Among authors: nicolay u. Vaccine. 2000 Dec 8;19(9-10):1055-60. doi: 10.1016/s0264-410x(00)00342-x. Vaccine. 2000. PMID: 11137239

7

Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine: A controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of Menjugate, stored at room temperature for 6 months.

Schöndorf I, Banzhoff A, Nicolay U, Diaz-Mitoma F. Schöndorf I, et al. Among authors: nicolay u. Vaccine. 2007 Jan 26;25(7):1175-82. doi: 10.1016/j.vaccine.2006.10.022. Epub 2006 Oct 27. Vaccine. 2007. PMID: 17095129 Clinical Trial.

8

Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience.

Nicolay U, Heijnen E, Nacci P, Patriarca PA, Leav B. Nicolay U, et al. Int J Infect Dis. 2019 Aug;85S:S1-S9. doi: 10.1016/j.ijid.2019.03.026. Epub 2019 Mar 26. Int J Infect Dis. 2019. PMID: 30926542 Free article.

9

Monitoring and safety assessment in Phase I to III clinical trials.

Fescharek R, Nicolay U, Arras-Reiter C. Fescharek R, et al. Among authors: nicolay u. Dev Biol Stand. 1998;95:203-9. Dev Biol Stand. 1998. PMID: 9855433

10

Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children and adults 65 years of age and older.

Lindert K, Leav B, Heijnen E, Barrett J, Nicolay U. Lindert K, et al. Among authors: nicolay u. Int J Infect Dis. 2019 Aug;85S:S10-S17. doi: 10.1016/j.ijid.2019.03.020. Epub 2019 Mar 20. Int J Infect Dis. 2019. PMID: 30904674 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters